After the fed raised interest rates stock markets are taking a ‘blood bath’ but Northwest (OTC: NWBO) shares could grow to $0.7390. At the time of writing the stock is fluctuating around that price on over 960k shares.
For two months NWBO has significantly surged from as low as $0.62. Four weeks ago the company announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the Company’s Pediatric Investigation Plan (PIP). Including its DCVax for adult patients will be undergoing a pre-requisite for application for approval.
This news could hold the stock above $0.70 until today. After approval NWBO is most likely to be riding above the $1 value.